Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
5.45
+0.71 (14.98%)
At close: Dec 5, 2025, 4:00 PM EST
5.95
+0.50 (9.17%)
After-hours: Dec 5, 2025, 7:57 PM EST
Pomdoctor Revenue
Pomdoctor had revenue of 192.39M CNY in the half year ending December 31, 2024, with 41.85% growth. This brings the company's revenue in the last twelve months to 366.86M, up 12.13% year-over-year. In the year 2024, Pomdoctor had annual revenue of 342.56M with 12.37% growth.
Revenue (ttm)
366.86M CNY
Revenue Growth
+12.13%
P/S Ratio
4.03
Revenue / Employee
2,351,688 CNY
Employees
156
Market Cap
645.51M undefined
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
POM News
- 2 days ago - POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results - PRNewsWire
- 7 weeks ago - Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program - Business Wire
- 2 months ago - U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown - Seeking Alpha
- 2 months ago - POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option - PRNewsWire
- 2 months ago - PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules - Benzinga
- 2 months ago - POMDOCTOR LIMITED Announces Closing of Initial Public Offering - PRNewsWire
- 2 months ago - POMDOCTOR LIMITED Announces Pricing of Initial Public Offering - PRNewsWire
- 4 months ago - PomDoctor Files For Nasdaq IPO That May Be Overvalued - Benzinga